Blog

As NAMs models such as organoids gain traction across disease modeling, drug discovery, and personalized medicine, one major challenge persists - scaling high-throughput organoid screening efficiently and reproducibly.

A Historic NIH Decision That Changes the Research Landscape On July 7, 2025, the National Institutes of Health (NIH) announced it will no longer issue new funding opportunities that focus exclusively on animal models. From now on, all new NIH grant announcements must include - or allow for - human-relevant research approaches, often referred to as New Approach Methodologies (NAMs).    This shift means researchers seeking NIH funding must incorporate methods like organoids,...

Organoid360™ is a turnkey automation platform designed for modern 3D biology and organoid research. Built on the BioAssemblyBot® and pre-configured with plug-and-play BioApps®, Organoid360 enables reproducible, high-throughput organoid workflows with minimal setup. Researchers can accelerate organoid assays, drug screening, and discovery while reducing hands-on time and variability.